Keyphrases
China
100%
Peroxisome Proliferator-activated Receptor
100%
Pioglitazone
100%
Type 2 Diabetic Patients
100%
Receptor-interacting Protein Kinase 1 (RIPK1)
100%
Gene Polymorphism
100%
Receptor 2
100%
Patient Response
100%
Protein Tyrosine Phosphatase Receptor Type D
100%
Rs1801282
83%
Type 2 Diabetes Mellitus (T2DM)
50%
Postprandial Glucose
50%
Polymorphism
33%
Serum Triglycerides
33%
CC Genotype
33%
Differential Values
33%
Genotype
16%
Low Density
16%
Genetic Variants
16%
Diabetes Risk
16%
Therapeutic Efficacy
16%
Glycated Hemoglobin
16%
Cholesterol
16%
Fasting Plasma Glucose
16%
Risk Allele
16%
Healthy Controls
16%
High-density Lipoprotein Cholesterol (HDL-C)
16%
TT Genotype
16%
Dominant Model
16%
Chinese Population
16%
MALDI-TOF Mass Spectrometry
16%
Higher Differential
16%
Diabetes Susceptibility
16%
Biochemistry, Genetics and Molecular Biology
Gene Polymorphism
100%
Pioglitazone
100%
Peroxisome Proliferator-Activated Receptor
100%
Protein Tyrosine Phosphatase
100%
Glucose Blood Level
66%
Genotyping
33%
Triacylglycerol Blood Level
33%
Genetic Divergence
16%
Matrix-Assisted Laser Desorption-Ionization
16%
HDL-Cholesterol
16%
Mass Spectrometry
16%
Allele
16%
Cholesterol Blood Level
16%
Glycated Hemoglobin
16%